Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
568-04-005 ISMRM Abstract

Synthetic Magnetic Resonance Imaging combined with Amide Proton Transfer-weighted Imaging in Grading of Prostate Cancer

Primary: Body - Prostate
Secondary: Analysis Methods - Visualization
568-04-005 · Prostate: Technical Applications, Sequences, and Coil Development · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row I
Keywords: Prostate cancer Amide proton transfe weighted imaging Synthetic MRI Gleason grade
Accepted
Zeyu Zhao 1, Jie Shi2, Jie Bao1, Qian Zhang3, Chenhan Hu1, Xiaomeng Qiao1, Minrui Zhou1, Ximing Wang1
1Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China
2MR Research, Beijing, China
3Radiology department, The First Affiliated Hospital of Soochow University, Suzhou, China
Presenting Author: Zeyu Zhao

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Caglic I, Kovac V, Barrett T. Multiparametric MRI - local staging of prostate cancer and beyond. Radiol Oncol. 2019;53(2):159-170. Published 2019 May 8. doi:10.2478/raon-2019-0021 [doi]
2. CUI Y D, HAN S Y, LIU M, et al. Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI. J Magn Reson Imaging, 2020, 52(2): 552-564. doi:10.1002/jmri.27075 [doi]
3. Gao Z, Xu X, Sun H, et al. The value of synthetic magnetic resonance imaging in the diagnosis and assessment of prostate cancer aggressiveness. Quant Imaging Med Surg. 2024;14(8):5473-5489. doi:10.21037/qims-24-291 [doi]
4. GUO Z X, QIN X Y, MU R H, et al. Amide Proton Transfer Could Provide More Accurate Lesion Characterization in the Transition Zone of the Prostate. J Magn Reson Imaging, 2022,56(5):1311-1319. doi:10.1002/jmri.28204 [doi]
5. Takayama Y, Nishie A, Sugimoto M, et al. Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores. MAGMA. 2016;29(4):671-679. doi:10.1007/s10334-016-0537-4 [doi]
6. LANGER D L, VAN DER KWAST T H, EVANS A J, et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. Radiology ,2008,249(3):900-908. doi:10.1148/radiol.2493080236 [doi]
7. MA J L, ABUBRIG M, LEHMANN T, et al. T2 Mapping in Prostate Cancer. Invest Radiol, 2019,54(3):146-152. doi:10.1097/RLI.0000000000000520 [doi]
8. Yang L, Wang L, Tan Y, et al. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging. 2023;23(1):3. Published 2023 Jan 7. doi:10.1186/s40644-022-00515-w [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/568-04-005